Literature DB >> 688579

The clinical significance of bundle branch block complicating acute myocardial infarction. 1. Clinical characteristics, hospital mortality, and one-year follow-up.

M C Hindman, G S Wagner, M JaRo, J M Atkins, M M Scheinman, R W DeSanctis, A H Hutter, L Yeatman, M Rubenfire, C Pujura, M Rubin, J J Morris.   

Abstract

To provide an understanding of the clinical characteristics of patients with acute myocardial infarction (MI) and bundle branch block, experience from five centers was accumulated. Patients in whom bundle branch block first appeared after the onset of cardiogenic shock were excluded. In 432 patients, the most common types of block were left (38%) and right with left anterior fascicular block (34%). In 42% of the patients, bundle branch block was new. Progression to high degree (second or third degree) atrioventricular (AV) block via a Type II pattern occurred in 22% of the patients. Hospital and first year follow-up mortality rates were 28% and 28%, respectively. Only 46% of the patients developed pulmonary edema or shock (Killip Class III or IV), and hospital mortality was related to the amount of heart failure (8%, 7%, 27%, 83% for Killip Classes I-IV, respectively). Patients with progression to second degree or third degree AV block via a Type II pattern had increased hospital mortality compared with patients without this complication (47% vs 23%, P less than 0.001). In the absence of pulmonary edema or shock, patients with Type II second degree or third degree AV block still had a higher mortality rate than patients without advanced AV block (31% vs 2%, P less than 0.005), with nearly all the deaths due to abrupt development of AV block. Thus, in many patients MI with bundle branch block is associated with severe heart failure. However, this was not true for a majority of the patients, in whom therapy aimed at preventing morbidity and mortality due to the bradyarrhythmia of advanced AV block might be beneficial.

Entities:  

Mesh:

Year:  1978        PMID: 688579     DOI: 10.1161/01.cir.58.4.679

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  25 in total

1.  Electrocardiographic diagnosis of acute myocardial infarction in the presence of left bundle branch block.

Authors:  W J Brady; F Morris
Journal:  J Accid Emerg Med       Date:  1999-07

2.  Heart Block and Conduction Disturbances.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  1999-08

3.  Simplifying thrombolysis decisions in patients with left bundle branch block.

Authors:  A D Reuben; C J Mann
Journal:  Emerg Med J       Date:  2005-09       Impact factor: 2.740

4.  Chest pain and left bundle branch block.

Authors:  D L Glancy; B Khuri
Journal:  Proc (Bayl Univ Med Cent)       Date:  2001-10

5.  [Acute thoracic aortic dissection with occlusion of the left coronary artery].

Authors:  M Weber; S Kerber; A Rahmel; G Breithardt; S Diallo; W Böcker
Journal:  Herz       Date:  1997-04       Impact factor: 1.443

Review 6.  Permanent pacing.

Authors:  P Bloomfield; H C Miller
Journal:  Br Med J (Clin Res Ed)       Date:  1987-09-26

7.  Left Bundle Branch Block and Complete Heart Block Complicating Inferior Myocardial Infarction.

Authors:  Jillian S Gruber; Brad Stair; Mehmet Aktas; Katia Bravo-Jaimes
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-07-13       Impact factor: 1.468

8.  Suspected myocardial infarction and left bundle branch block: electrocardiographic indicators of acute ischaemia.

Authors:  J A Edhouse; M Sakr; J Angus; F P Morris
Journal:  J Accid Emerg Med       Date:  1999-09

9.  Prognostic value of stress myocardial perfusion single photon emission computed tomography imaging in patients with left ventricular bundle branch block.

Authors:  N Nallamothu; B Bagheri; E R Acio; J Heo; A E Iskandrian
Journal:  J Nucl Cardiol       Date:  1997 Nov-Dec       Impact factor: 5.952

10.  Post-myocardial infarction intraventricular conduction defects and B-type natriuretic peptide levels.

Authors:  Katarzyna Ciuraszkiewicz; Marianna Janion; Janusz Sielski; Dariusz Dudek; Zenon Gawor
Journal:  Clin Cardiol       Date:  2009-06       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.